Condensation properties of stress granules and processing bodies are compromised in myotonic dystrophy type 1

被引:2
|
作者
Gulyurtlu, Selma [1 ]
Magon, Monika S. [1 ]
Guest, Patrick [1 ]
Papavasiliou, Panagiotis P. [1 ]
Morrison, Kim D. [1 ]
Prescott, Alan R. [2 ]
Sleeman, Judith E. [1 ]
机构
[1] Univ St Andrews, Sch Biol, Biomol Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland
[2] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland
基金
英国惠康基金; 美国安德鲁·梅隆基金会; 英国生物技术与生命科学研究理事会;
关键词
LLPS; Myotonic dystrophy type 1; P-bodies; Stress granules; Trinucleotide repeats; MESSENGER-RNA; BINDING PROTEIN; OXIDATIVE STRESS; CAJAL BODY; TOXIC RNA; LOCALIZATION; TRANSLATION; AUTOPHAGY; CUGBP1; MODEL;
D O I
10.1242/dmm.049294
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
RNA regulation in mammalian cells requires complex physical compartmentalisation, using structures thought to be formed by liquid-liquid phase separation. Disruption of these structures is implicated in numerous degenerative diseases. Myotonic dystrophy type 1 (DM1) is a multi-systemic trinucleotide repeat disorder resulting from an expansion of nucleotides CTG (CTGexp) in the DNA encoding DM1 protein kinase (DMPK). The cellular hallmark of DM1 is the formation of nuclear foci that contain expanded DMPK RNA (CUGexp) (with thymine instead of uracil). We report here the deregulation of stress granules (SGs) and processing bodies (P-bodies), two cytoplasmic structures key for mRNA regulation, in cell culture models of DM1. Alterations to the rates of formation and dispersal of SGs suggest an altered ability of cells to respond to stress associated with DM1, while changes to the structure and dynamics of SGs and P-bodies suggest that a widespread alteration to the biophysical properties of cellular structures is a consequence of the presence of CUGexp RNA.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1
    Tahraoui-Bories, Julie
    Merien, Antoine
    Gonzalez-Barriga, Anchel
    Laine, Jeanne
    Leteur, Celine
    Polveche, Helene
    Carteron, Alexandre
    De Lamotte, Juliette Duchesne
    Nicoleau, Camille
    Polentes, Jerome
    Jarrige, Margot
    Gomes-Pereira, Mario
    Ventre, Erwann
    Poydenot, Pauline
    Furling, Denis
    Schaeffer, Laurent
    Legay, Claire
    Martinat, Cecile
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (01)
  • [42] A single dose of exercise stimulates skeletal muscle mitochondrial plasticity in myotonic dystrophy type 1
    Mikhail, Andrew I.
    Manta, Alexander
    Ng, Sean Y.
    Osborne, Aislin K.
    Mattina, Stephanie R.
    Mackie, Mark R.
    Ljubicic, Vladimir
    ACTA PHYSIOLOGICA, 2023, 237 (04)
  • [43] Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
    Bargiela, Ariadna
    Cerro-Herreros, Estefania
    Fernandez-Costa, Juan M.
    Vilchez, Juan J.
    Llamusi, Beatriz
    Artero, Ruben
    DISEASE MODELS & MECHANISMS, 2015, 8 (07) : 679 - 690
  • [44] A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients
    Degener, Max J. F.
    van Cruchten, Remco T. P.
    Otero, Brittney A.
    Wang, Eric T.
    Wansink, Derick G.
    't Hoen, Peter A. C.
    NAR GENOMICS AND BIOINFORMATICS, 2022, 4 (01)
  • [45] Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity
    Nunez-Manchon, Judit
    Capo, Julia
    Martinez-Pineiro, Alicia
    Juanola, Eduard
    Pesovic, Jovan
    Mosqueira-Martin, Laura
    Gonzalez-Imaz, Klaudia
    Maestre-Mora, Pau
    Odria, Renato
    Savic-Pavicevic, Dusanka
    Vallejo-Illarramendi, Ainara
    Mamchaoui, Kamel
    Bigot, Anne
    Mouly, Vincent
    Suelves, Monica
    Nogales-Gadea, Gisela
    ISCIENCE, 2024, 27 (06)
  • [46] Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model
    Sabater-Arcis, Maria
    Moreno, Nerea
    Sevilla, Teresa
    Alonso, Manuel Perez
    Bargiela, Ariadna
    Artero, Ruben
    BIOMEDICAL JOURNAL, 2024, 47 (04)
  • [47] Fluoxetine Blocks Myotonic Runs and Reverts Abnormal Surface Electromyogram Pattern in Patients With Myotonic Dystrophy Type 1
    Chisari, Carmelo
    Licitra, Rosaria
    Pellegrini, Monica
    Pellegrino, Mario
    Rossi, Bruno
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (06) : 330 - 334
  • [48] Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1
    Koebis, Michinori
    Ohsawa, Natsumi
    Kino, Yoshihiro
    Sasagawa, Noboru
    Nishino, Ichizo
    Ishiura, Shoichi
    GENES TO CELLS, 2011, 16 (09) : 961 - 972
  • [49] Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1
    Sharp, Lydia
    Cox, Diana C.
    Cooper, Thomas A.
    MUSCLE & NERVE, 2019, 60 (06) : 779 - 789
  • [50] Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules
    Pager, Cara T.
    Schuetz, Sylvia
    Abraham, Teresa M.
    Luo, Guangxiang
    Sarnow, Peter
    VIROLOGY, 2013, 435 (02) : 472 - 484